By a News Reporter-Staff News Editor at Biotech Business Week -- BioNeutral Group, Inc. (OTCBB: BONU) (OTCQB: BONU) announced that it has entered into a product distribution agreement with BioTech Medical Inc. (BTM), a manufacturer and national distributor of products to medical facilities, federal government agencies and cost containment organizations.
The new agreement will allow BioNeutral to drive a deeper relationship with our YGIENE™ and OGIENE™ lines into the health care marketplace.
Andrea L. Goren, Executive Director of BioTech Medical, Inc., said, "According to the EPA (Environmental Protection Agency) 100% of all types of mold have the potential to cause harmful health effects. This can be minor to severe and even death in some rare cases. YGIENE 206 is the first product we have found that kills ALL types of mold in less than five-minutes. In fact, compared with traditional antimicrobial agents, YGIENE 206 has superior efficacy, reduced toxicity and is labeled by the EPA as a cleaner, disinfectant, and sterilant. A sterilant kills all forms of microbial life on inanimate environmental surfaces." Ms. Goren closes by saying, "We are passionate about raising health standards through the identification and distribution of new and innovative infection control technologies and BioNeutral has proved to be strides ahead of their competition."
Ray Dunning, Sr. Vice President of Sales, commented, "BioNeutral is very excited to be working with an organization like BioTech Medical with their reach to over 1,000 customers and distributors. BioTech Medical is well respected in our industry and has a sales team that possesses the professionalism and technical knowledge required to bring our new technologies to the medical marketplace."
Keywords for this news article include: Biotechnology, Environment, Government Agencies, Offices and Entities (see also Environment).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC